DRAX ENERGY SOLUTIONS LIMITED

Financial Health Assessment: DRAX ENERGY SOLUTIONS LIMITED

1. Financial Health Score: A-

Explanation: Based on the available corporate vitals, this company exhibits a robust constitution and excellent administrative health. The score sits at an A- rather than a perfect A solely because the specific financial "blood test" results (balance sheet, P&L figures) were not provided in this dataset to confirm internal cash flow and profitability. However, structurally and compliantly, the patient is in excellent shape, exhibiting no symptoms of distress and benefiting from the robust genetics of a major corporate parent.

2. Key Vital Signs

• Compliance Pulse (Filing History): Strong and Steady. The company’s accounts are filed up to a remarkably forward-looking date (December 2025) with the next deadline not until September 2027. The confirmation statement is also up to date. This regular, unobstructed heartbeat of compliance indicates no administrative arrhythmias or signs of corporate distress.
• Corporate DNA (Ownership Structure): Highly Resilient. The patient is wholly owned and controlled by entities within the Drax Group (Drax Smart Supply Holdco Limited, Drax Corporate Limited, and Drax Power Limited). Having multiple parent entities holding >75% control provides a massive corporate "immune system"—meaning this company has deep-pocketed backing to weather market volatility.
• Corporate Age (Incorporation): Mature Constitution. Incorporated in 2006, this business is approaching its two-decade mark. It has survived multiple economic cycles, proving it has a resilient constitution rather than the fragility often seen in start-ups.
• Capital Reserves: Nominal. The share capital is a mere £101. While this looks alarmingly thin on the surface, in a large corporate group, this is entirely normal. The business is likely financed through inter-company "blood transfusions" (loans from the parent) rather than share capital, which is a standard structural setup for group subsidiaries.
• Corporate Identity (Historical M&A): The name change from Haven Power Limited in 2021 indicates a successful "organ transplant"—the business has been fully integrated and rebranded into the Drax ecosystem.

3. Diagnosis

The patient is in excellent structural and administrative health. There are absolutely no symptoms of distress, insolvency, or administrative neglect. The company files "Full" accounts rather than claiming micro-entity or small company exemptions, which tells us it meets the criteria of at least a medium-sized business, requiring a higher degree of financial transparency.

The lack of specific P&L or balance sheet figures in this specific dataset means we cannot measure the patient's "cholesterol" (profit margins) or "blood pressure" (cash flow liquidity) directly. However, operating in the UK energy generation and trade sector (SIC 35140) under the protective umbrella of the Drax Group suggests this entity is a strategically important organ to the wider corporate body, tasked with delivering energy solutions rather than operating as a standalone risk-taking venture.

4. Recommendations

While the patient is structurally healthy, the following steps are recommended to maintain peak financial wellness: * Monitor Inter-Company Dependency: Because the share capital is only £101, the business relies heavily on parent company financing. It is vital to ensure that the "blood transfusions" (inter-company loans) from Drax Group are on commercially reasonable terms and do not create an unsustainable debt burden if group policies change. * Review Group Consolidated Accounts: To get a true reading of this company's financial blood pressure, one must look at the Drax Group plc consolidated accounts. Treat the parent company's annual report as the full-body MRI scan to understand how this specific subsidiary contributes to the group's overall circulation of cash. * Maintain Compliance Hygiene: Continue the exemplary track record of timely filings. In the heavily regulated UK energy sector, any compliance lapse (a fever) can attract regulatory scrutiny, which is easily avoided by maintaining the current administrative discipline.